Søren Helweg Dam

Søren Helweg Dam

Auto-generated profile, based on publicly available information

Søren Helweg Dam

DTU Health Tech, Technical University of Denmark, Ørsteds Plads, Kongens Lyngby, Denmark

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2023 in Analytica Chimica Acta
Verified
Journal Article
Open access
CKCecilie Knudsen
Cecilie Knudsen
JJJonas A. Jürgensen
Jonas A. Jürgensen
PKPelle D. Knudsen
Pelle D. Knudsen
IOIrina Oganesyan
Irina Oganesyan
JHJulian A. Harrison
Julian A. Harrison
Andreas LaustsenAndreas Laustsen
Andreas Laustsen
Brazil is home to a multitude of venomous snakes; perhaps the most medically relevant of which belong to the Bothrops genus. Bothrops spp. are responsible for roughly 70% of all snakebites in Brazil, and envenomings caused by their bites can be treated with three types of antivenom: bothropic antivenom, bothro-lachetic antivenom, and bothro-crotalic antivenom. The choice to administer antivenom depends on the severity of the envenoming, while the choice of antivenom depends on availability and on how certain the treating physician is that the patient was bitten by a bothropic snake. The diagnosis of a bothropic envenoming can be made based on expert identification of the dead snake or a photo thereof or based on a syndromic approach wherein the clinician examines the patient for characteristic manifestations of envenoming. This approach can be very effective but requires staff that has been trained in clinical snakebite management, which, unfortunately, far from all relevant staff has. In this article, we describe a prototype of the first lateral flow assay (LFA) capable of detecting venoms from Brazilian Bothrops spp. The monoclonal antibodies for the assay were generated using hybridoma technology and screened in sandwich enzyme-linked immunosorbent assays (ELISAs) to identify Bothrops spp.-specific antibody sandwich pairs. The prototype LFA is able to detect venom from several Bothrops spp. The LFA has a limit of detection (LoD) of 9.5 ng/mL in urine, when read with a commercial reader, and a visual LoD of approximately 25 ng/mL. The work presented here serves as a proof of concept for a genus-specific venom detection kit that could support physicians in diagnosing Bothrops envenomings. Although further optimisation and testing is needed before the LFA can find clinical use, such a device could aid in decentralising antivenoms in the Brazilian Amazon and help ensure optimal snakebite management for even more victims of this highly neglected disease.

1 May 2024 in Cytotherapy
Verified
Journal Article
Open access
PAPia Aehnlich
Pia Aehnlich
MSMarta Velasco Santiago
Marta Velasco Santiago
SDSøren Helweg Dam
Søren Helweg Dam
SSSara Fresnillo Saló
Sara Fresnillo Saló
ARAnne Rahbech
Anne Rahbech
GOGitte Holmen Olofsson
Gitte Holmen Olofsson
Background aims: Vy9VS2 T cells are under investigation as alternative effector cells for adoptive cell therapy (ACT) in cancer. Despite promising in vitro results, anti-tumor efficacies in early clinical studies have been lower than expected, which could be ascribed to the complex interplay of tumor and immune cell metabolism competing for the same nutrients in the tumor microenvironment. Methods: To contribute to the scarce knowledge regarding gamma delta T-cell metabolism, we investigated the metabolic phenotype of 25-day-expanded Vy9VS2 T cells and how it is intertwined with functionality. Results: We found that Vy9VS2 T cells displayed a quiescent metabolism, utilizing both glycolysis and oxidative phosphorylation (OXPHOS) for energy production, as measured in Seahorse assays. Upon T-cell receptor activation, both pathways were upregulated, and inhibition with metabolic inhibitors showed that Vy9VS2 T cells were dependent on glycolysis and the pentose phosphate pathway for proliferation. The dependency on glucose for proliferation was confirmed in glucose-free conditions. Cytotoxicity against malignant melanoma was reduced by glycolysis inhibition but not OXPHOS inhibition. Conclusions: These findings lay the groundwork for further studies on manipulation of Vy9VS2 T-cell metabolism for improved ACT outcome. (c) 2024 International Society for Cell & Gene Therapy. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)

27 June 2025 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJieran Sun
Jieran Sun
KBKirti Biharie
Kirti Biharie
PCPeiying Cai
Peiying Cai
NMNiklas Mueller-Boetticher
Niklas Mueller-Boetticher
PKPaul Kiessling
Paul Kiessling
Naveed IshaqueNaveed Ishaque
Naveed Ishaque
Spatial omics technologies have revolutionized the study of tissue architecture and cellular heterogeneity by integrating molecular profiles with spatial localization. In spatially resolved transcriptomics, delineating higher-order anatomical structures is critical for understanding how cellular organization affects tissue and organ function. Since 2020, more than 50 spatially aware clustering (SAC) methods have been developed for this purpose. However, the reliability of current benchmarks is undermined by their narrow focus on Visium and brain tissue datasets, as well as incorrect interpretation of manual annotation as ground truth. Here, we present SACCELERATOR, a community-driven, extensible framework that standardizes data formatting, method integration, and metric evaluation, and is designed to rapidly incorporate new methods and datasets. SACCELERATOR currently includes 22 SAC methods applied to 15 datasets spanning 9 technologies and diverse tissue types. Our analysis revealed substantial limitations in the generalizability and reproducibility of SAC methods across tissues and platforms. We also demonstrate that anatomical labels commonly used as ground truths are often biased, potentially error-prone, and, in some cases, unsuitable for benchmarking efforts. Rather than scoring and comparing methods, we propose a consensus-guided workflow that aggregates clustering results to generate consensus representations. Descriptive spatial metrics highlight areas of high entropy where method disagreement is highest, enabling targeted feedback for tissue experts. Applied to brain and cancer datasets, this approach uncovered biologically meaningful patterns overlooked by individual methods and manual annotations. Our results underscore the need for iterative, expert-in-the-loop analysis and reveal that traditional evaluation metrics do not always capture the subjective qualities of results. By improving tissue annotation and addressing key benchmarking limitations, SACCELERATOR provides a robust foundation for advancing spatial omics research.

24 August 2026 in Nature Methods
Verified
Journal Article
Open access
PDF file
JSJieran Sun
Jieran Sun
KBKirti Biharie
Kirti Biharie
PCPeiying Cai
Peiying Cai
NMNiklas Müller-Bötticher
Niklas Müller-Bötticher
PKPaul Kiessling
Paul Kiessling
Naveed IshaqueNaveed Ishaque
Naveed Ishaque
Spatial omics technologies have revolutionized the study of tissue architecture and cellular heterogeneity by integrating molecular profiles with spatial localization. In spatially resolved transcriptomics, delineating higher-order anatomical structures is critical for understanding how cellular organization affects function. However, the reliability of current benchmarks of spatially aware clustering (SAC) methods is undermined by their narrow focus on Visium and brain tissue datasets and the incorrect interpretation of manual annotation as ground truth. Here we present SACCELERATOR, a community-driven, extensible framework that standardizes data formatting, method integration and metric evaluation, enabling rapid inclusion of new methods and datasets. Our analysis revealed substantial limitations in the generalizability and reproducibility of SAC methods and shows that anatomical labels commonly used as ground truths are often biased, error prone and unsuitable for benchmarking. Rather than ranking methods, we propose a consensus-guided workflow where descriptive spatial metrics highlight high-entropy regions of method disagreement, enabling targeted feedback for tissue experts. Applied to brain and cancer datasets, this approach uncovered biologically meaningful patterns overlooked by individual SAC methods and manual annotations, highlighting the need for iterative, expert-in-the-loop evaluation.

29 August 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
SDSøren Helweg Dam
Søren Helweg Dam
Lars Rønn OlsenLars Rønn Olsen
Lars Rønn Olsen
KVKristoffer Vitting-Seerup
Kristoffer Vitting-Seerup
Background: Through alternative splicing, most human genes produce multiple isoforms in a cell-, tissue-, and disease-specific manner. Numerous studies show that alternative splicing is essential for development, diseases and their treatments. Despite these important examples, the extent and biological relevance of splicing are currently unknown. Results: To solve this problem, we developed pairedGSEA and used it to profile transcriptional changes in 100 representative RNA-seq datasets. Our systematic analysis demonstrates that changes in splicing, on average, contribute to 48.1% of the biological signal in expression analyses. Gene-set enrichment analysis furthermore indicates that expression and splicing both convey shared and distinct biological signals. Conclusion: These findings establish alternative splicing as a major regulator of the human condition and suggest that most contemporary RNA-seq studies likely miss out on critical biological insights. We anticipate our results will contribute to the transition from a gene-centric to an isoform-centric research paradigm.

27 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
CKCecilie Knudsen
Cecilie Knudsen
JJJonas A. Jürgensen
Jonas A. Jürgensen
PKPelle D. Knudsen
Pelle D. Knudsen
IOIrina Oganesyan
Irina Oganesyan
JHJulian A. Harrison
Julian A. Harrison
Andreas LaustsenAndreas Laustsen
Andreas Laustsen
Background: Brazil is home to a multitude of venomous snakes, perhaps the most medically relevant of which belong to the Bothrops genus. Bothrops spp . are responsible for roughly 70% of all snakebites in Brazil, and envenomings caused by their bites can be treated with three types of antivenom: bothropic antivenom, bothro-lachetic antivenom, and bothro-crotalic antivenom. The choice in antivenom that is administered depends not only on its availability and how certain the treating physician is that the patient was bitten by a bothropic snake. The diagnosis of a bothropic envenoming can be made based on expert identification of a photo of the snake or based on a syndromic approach wherein the clinician examines the patient for characteristic manifestations of envenoming. This approach can be very effective but requires staff that has been trained in clinical snakebite management, which, unfortunately, far from all relevant staff has. Results: In this paper, we describe a prototype of the first lateral flow assay (LFA) capable of detecting venoms from Brazilian Bothrops spp . The monoclonal antibodies for the assay were generated using hybridoma technology and screened in sandwich enzyme-linked immunosorbent assays (ELISAs) to identify Bothrops spp . specific antibody sandwich pairs. The sandwich pairs were used to develop a prototype LFA that was able to detect venom from several different Bothrops spp . The limit of detection (LoD) of the prototype was evaluated using Brazilian B. atrox whole venom and was determined to be 8.0 ng/mL in spiked serum samples and 9.5 ng/mL in spiked urine samples, when using a portable reader, and < 25 ng/mL in spiked buffer when reading by eye. Significance: The work presented here serves as a proof of concept of a genus-specific venom detection kit, which could support physicians in diagnosing Bothrops envenomings. Although further optimization and testing is needed before the LFA can find clinical use, such a device could aid in decentralizing antivenoms in the Brazilian Amazon and help ensure optimal snakebite management for even more victims of this highly neglected disease.